Human ADCY10 CRISPR Knock Out 293T Cell Line

Cell line type

293T
NCBI number

NM_018417
Availability

Please contact us every day to check the availability and/or to request a quote. For larger or bulk quantities a discount may apply.
Ordering

If you wish to order this product, please include the catalogue number #K0048351in your purchase order among with your shipping and billing information.
Technical file

Please contact us to request the latest datasheet, protocol, certificate of analysis and SDS files.
Notes

Designed for Research Use Only. Manufactured in Canada.
Other products
Description

For cells, cell lines and tissues in culture till half confluency.
Properties

Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.

Gene target

ADCY10 CRISPR Knock Out Line
Gene symbol

ADCY10
Short name

ADCY10 CRISPR Knock Out Line
Technique

CV40 transformed cell line or 293tsA1609neo from human kidney 293 cells delivered as 1.
Species

Human, Humans
Alternative name

H. sapiens adenylate cyclase 10 (soluble) CRISPR Knock Out 293T cellular Line
Alternative to gene target

adenylate cyclase 10 (soluble), ADCY10 and IDBG-104569 and ENSG00000143199 and 55811, ATPase binding, Plasma membranes, Adcy10 and IDBG-202672 and ENSMUSG00000026567 and 271639, ADCY10 and IDBG-629473 and ENSBTAG00000001052 and 521844
Tissue

cell

Name

Transformation, Bacterial
Concept

Scope note: The heritable modification of the properties of a competent bacterium by naked DNA from another source. The uptake of naked DNA is a naturally occuring phenomenon in some bacteria. It is often used as a GENE TRANSFER TECHNIQUE.
Tree numbers
- E05.393.350.810.500
Qualifiers

immunology, physiology, ethics, drug effects, radiation effects, genetics